The Horseracing Integrity and Safety Authority's Anti-Doping and Medication Control program has now been in effect for one month, meaning there is one set of rules and one agency administering those rules throughout the United States (with the exceptions of Texas, whose racing commission chose not to join HISA, and Louisiana and West Virginia, which are involved in litigation that has temporarily exempted them).
“As you can imagine, it's been a massive undertaking to bring all anti-doping testing under one entity, under one system,” said Lisa Lazarus, the CEO of HISA who joins Ray Paulick and bloodstock editor Joe Nevills this week on the Friday Show. “I'm incredibly pleased with how it's gone from an operational standpoint.”
Lazarus cited the professionalism of the Horseracing Integrity & Welfare Unit, which HISA has retained to administer the ADMC rules and enforcement. HIWU is part of Drug Free Sport International, which has anti-doping contracts with numerous amateur and professional sports, including the NCAA, NFL, NBA/WNBA, NASCAR, MLB, and NASCAR.
The ADMC program streamlines the process when adverse findings are detected in samples, said Lazarus, who also outlined how the agency's “atypical findings policy” is designed to prevent obvious contaminations from being prosecuted as doping violations.
Lazarus also provides updates on HISA's Racetrack Safety Program in this wide-ranging interview.
Watch this week's episode of The Friday Show below:
The post The Friday Show Presented By The Jockey Club: Progress Report From HISA’s Lisa Lazarus appeared first on Horse Racing News | Paulick Report.
